Navellier & Associates Inc Clear Point Neuro, Inc. Transaction History
Navellier & Associates Inc
- $792 Million
- Q4 2024
A detailed history of Navellier & Associates Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Navellier & Associates Inc holds 50,000 shares of CLPT stock, worth $836,000. This represents 0.1% of its overall portfolio holdings.
Number of Shares
50,000
Previous 50,000
-0.0%
Holding current value
$836,000
Previous $560,000
37.32%
% of portfolio
0.1%
Previous 0.08%
Shares
1 transactions
Others Institutions Holding CLPT
# of Institutions
93Shares Held
7.57MCall Options Held
390KPut Options Held
28.7K-
Vanguard Group Inc Valley Forge, PA1.25MShares$20.9 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA509KShares$8.51 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA409KShares$6.84 Million1.22% of portfolio
-
Black Rock Inc. New York, NY366KShares$6.13 Million0.0% of portfolio
-
Brown Advisory Inc333KShares$5.57 Million0.01% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $409M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...